Wasatch Advisors Inc Sangamo Therapeutics, Inc Transaction History
Wasatch Advisors Inc
- $18.4 Billion
- Q2 2025
A detailed history of Wasatch Advisors Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 8,084,419 shares of SGMO stock, worth $5.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,084,419
Previous 6,868,766
17.7%
Holding current value
$5.5 Million
Previous $4.53 Million
3.71%
% of portfolio
0.02%
Previous 0.03%
Shares
33 transactions
Others Institutions Holding SGMO
# of Institutions
126Shares Held
50.8MCall Options Held
1.1MPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA9.37MShares$6.37 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$4.65 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$3.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.59 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X02.25MShares$1.53 Million0.09% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $106M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...